27- Physician-Executive Series: Olivia Cavlan, MD (Alchemab)

Episode 27 June 29, 2022 00:43:53
27- Physician-Executive Series: Olivia Cavlan, MD (Alchemab)
Physicians Off The Beaten Path
27- Physician-Executive Series: Olivia Cavlan, MD (Alchemab)
/

Show Notes

What kind of opportunities medical students have if they don’t want a traditional medical career? Why is it important to think about medical training as a platform, rather than a predetermined path? In this episode, we answer all of these questions and more, with our guest, Olivia Cavlan MD.

Olivia is Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.

Olivia holds an MD in Medicine and a BSc in Pharmacology from Bristol University where she graduated with the top First Class Honors.

Other Episodes

Episode 09

October 20, 2021 00:46:49
Episode Cover

09- Physician-Banker Series: Alex Lomax, MD (Lazard)

How do investment banking and financial advisory play a role in facilitating thetransformation and innovation in the healthcare ecosystem? Can you develop a business acumen without an MBA degree? In this episode, we answer all these questions and more with our guest, Alex Lomax, M.D.Alex is a Vice President of Healthcare Financial Advisory at Lazard, the world’s largest financial advisory-focused firm. Lazard advises clients on M&A and Strategic Advisory, Middle Market, Sovereign Advisory, Restructuring, Shareholder & Private Capital Advisory, and Venture & Growth Banking.Lazard has advised on many of the largest deals in the healthcare space such as the merger of Livongo & Teladoc and the Acquisition of Aetna by CVS health. Before Lazard, Alex was an associate and then vice president of Healthcare Investment Banking at RBC Capital Markets. He was also an Investment Banking Analyst at Peel Hunt for two years.  ...

Listen

Episode 28

July 13, 2022 00:48:24
Episode Cover

28- Physician-Scientist Series: Shaheen Lakhan, MD (Click Therapeutics)

What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about entrepreneurship and innovation, like DTx for example, where their experience and clinical knowledge is actually needed? In this episode, we answer all these questions and more, with our guest, Dr. Shaheen Lakhan. Shaheen is the CMO of Click Therapeutics, A prescription digital therapeutics company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs.  Shaheen is a physician-scientist with over 15 years of experience in healthcare, academia, and industry focusing on neuroscience research and development. Shaheen is board-certified in both neurology and pain medicine, with clinical training from Cleveland Clinic and Massachusetts General Hospital. ...

Listen

Episode 31

September 07, 2022 00:40:57
Episode Cover

31- Physician-Scientist Series: Mansur Shomali (Welldoc)

  How can AI innovation help in transforming the future of Endocrinology? What are the main problems we have with the US healthcare system, and what roles can MDs have in solving these problems? In this episode, we answer all these questions and more, with our guest, Mansur Shomali, M.D. He is Chief Medical Officer at Welldoc, a healthcare technology company that develops solutions to transform the management of chronic disease. Mansur received his undergraduate degree in biomedical engineering at the Johns Hopkins University and his medical degree from McGill University in Montreal, Canada.   ...

Listen